Inside the First Cannabis Company to List on Nasdaq
Cronos Group started trading on the Nasdaq Tuesday. The vertically integrated company became the first marijuana company to join a major exchange in the United States. The company's CEO Mike Gorenstein explains how Cronos is capitalizing on the emerging market in Canada.
"Entering the U.S. market is really big for us," said Gorenstein. "It continues to show the acceptance the Cannabis industry is getting, and the recognition of how important Cannabis can be."
Cronos Group fully owns two subsidiary companies Peace Naturals and Original BC (OGBC), with partial stake in Whistler Medical Marijuana Company.
Americans are still spending, but rising anxiety over jobs, AI, housing and tariffs tells a different story. Kearney Consumer Institute’s Katie Thomas explains.
Disney is back in focus after Q3 earnings. Investors are watching streaming profits, theme parks and ESPN as the entertainment giant looks for its next catalyst
Healthcare policy is shifting fast, raising questions about drug prices, Medicare and access. Leap Health CEO Hani Elias explains what patients need to know.
The U.S. job market is cooling as hiring slows and employers turn cautious. LinkedIn’s Kory Kantenga breaks down jobs, wages, spending and AI’s impact.
AI is entering a new phase as enterprises move beyond experimentation and demand measurable returns. Appian CEO Matt Calkins discusses what comes next.
Commercial Metals CEO Peter Matt reveals how a $2.5B acquisition spree is transforming the 111-year-old steelmaker into a construction solutions powerhouse.
Angelo Zino, Senior Vice President and Technology Equity Research Analyst at CFRA, breaks down Big Tech earnings, AI spending, and what's next for the Mag 7.
